Teva
Federal Trade Commission sues AbbVie and Teva
September 9, 2014Manufacturing and Production, Sales and Marketing AbbVie, FTC, Teva, androgel, federal trade commission
Authorities in the US claim that AbbVie and Teva filed ‘sham’ lawsuits in a complicated pay-to-delay case for generic forms …
Teva launches new MS eHealth site
September 4, 2014Medical Communications, Sales and Marketing Teva, digital, ms ireland, multiple sclerosis, pow health
Teva and MS Ireland have helped launch a new website called Pow Health to give multiple sclerosis patients a “one-stop …
Copycat Lipitor helps toward £1.3bn NHS savings
July 29, 2014Research and Development, Sales and Marketing ABPI, Lipitor, NHS, Teva, prescribing PPRS, vba
In 2013 generic usage increased to more than three-quarters of all NHS prescriptions according to new data released by the …
Servier fined €331m by European Commission
July 10, 2014Sales and Marketing EC, European Commission, France, Krka, Lupin, Matrix, Mylan, Niche/Unichem, Servier, Teva
The European Commission has served French pharma company Servier with a €331 million fine for delaying the entry to market …
Teva chairman stepping down amid revamp
June 19, 2014Manufacturing and Production, Medical Communications, Sales and Marketing Frost, Levin, Teva, chief, generics, israel, pharma
Having just announced closing half of its manufacturing sites Teva has now confirmed that chairman Dr Phillip Frost is to …
Teva to close half its sites
June 17, 2014Manufacturing and Production, Sales and Marketing Jobs, Teva, cuts, generics, manufacturing
Teva Pharmaceutical Industries is to close around half of its 75 manufacturing sites within the next five years, chief financial …
Teva considers up to 27 plant closures
May 13, 2014Manufacturing and Production, Sales and Marketing Copaxone, Nerventra, Teva, cuts, generics
Teva is to close 11 of its production sites, with another 16 facilities ‘under evaluation’, as part of a major …
Europe poised for generic Symbicort
February 24, 2014Manufacturing and Production, Sales and Marketing AstraZeneca, CHMP, COPD, Symbicort, Teva, breo, generics
The CHMP has given Teva Pharmaceutical Industries a lift by recommending that its generic version of AstraZeneca’s lung drug Symbicort …
CHMP breathes new life into GSK, Teva and Novartis
February 24, 2014Research and Development, Sales and Marketing CHMP, COPD, EMA, GSK, Gilead, Teva, asthma, onoro
The CHMP has given its backing to a number of new treatments for respiratory diseases, which include two from London-based …
Teva under investigation for marketing practices
February 12, 2014Sales and Marketing Azilect, Copaxone, Teva, fines, generics
Teva Pharmaceuticals is under investigation by US authorities for sales and marketing activity around two of its drugs – including …
Teva/VCCP on top at PM Society ad awards
February 3, 2014Medical Communications, Sales and Marketing 2014, Teva, ads, advertising, neil smith, pm awards, vccp
Teva and its agency partner VCCP took home the most wins from this year’s PM Society Advertising Awards that featured …
High-dose Copaxone the right medicine for Teva
January 29, 2014Research and Development, Sales and Marketing Biogen, Copaxone, FDA, MS, Mylan, Teva
The FDA has approved a high-dose version of Teva’s multiple sclerosis drug Copaxone which will help the firm offset approaching …
Teva’s Great White Hope knocked back by Europe
January 27, 2014Sales and Marketing CHMP, EU, MS, Nerventra, Teva
The drug designed to be a follow-up to Teva’s wildly successful Copaxone has been hit by rejection in Europe, leaving …
Teva names new chief executive
January 9, 2014Manufacturing and Production, Research and Development, Sales and Marketing Levin, Teva, erez vigodman, generics
The world’s biggest generic drugmaker Teva has appointed the chief executive of the world’s biggest generic agrochemical company. Vigodman joins …
Teva vice chairman quits
December 17, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Teva, amir elstein, moshe many
Teva Pharmaceuticals vice chairman Professor Moshe Many has requested to leave the firm at the end of this month for …
Latest content
Santen joins inaugural Global Summit for Eye Health as partner
